Literature DB >> 10412041

Cloning and characterization of the prostate-specific membrane antigen promoter.

D Good1, P Schwarzenberger, J A Eastham, R E Rhoads, J D Hunt, M Collins, M Batzer, C Theodossiou, J K Kolls, S R Grimes.   

Abstract

Prostate-specific membrane antigen (PSMA) is a protein that is expressed predominantly in normal prostate epithelial cells and in most adenocarcinomas of the prostate (Cap) and in virtually all Cap metastases. In this article we describe the cloning of a 2-kb human genomic DNA fragment containing the 5' upstream untranslated region of the PSMA gene and present evidence that it provides promoter activity. When the DNA fragment was cloned into transient expression vectors to examine promoter activity, the vectors were functional in promoting expression in several prostate and nonprostate cell lines in transient transfection assays. A 614-bp fragment derived from the 3' end of the 2-kb fragment may represent the minimal PSMA promoter as determined by deletion mutagenesis. The 2-kb fragment compared with the 614-bp fragment provided higher expression levels when using prostate-derived cell lines (DU 145 and LNCaP). The increased transcription using the 2-kb fragment was not as great in non-prostate cell lines. Little or no transcription over basal levels was seen with a 232-bp promoter fragment. When the concentration of dihydrotestosterone was depleted or supplemented in the growth medium, no significant effect was seen on PSMA-promoted transient expression in LNCaP cells, a prostate cell line. J. Cell. Biochem. 74:395-405, 1999. Published 1999 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10412041

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  4 in total

Review 1.  Influence of Androgen Deprivation Therapy on the Uptake of PSMA-Targeted Agents: Emerging Opportunities and Challenges.

Authors:  Martin K Bakht; So Won Oh; Hyewon Youn; Gi Jeong Cheon; Cheol Kwak; Keon Wook Kang
Journal:  Nucl Med Mol Imaging       Date:  2016-08-06

2.  Promoter analysis of human glutamate carboxypeptidase II.

Authors:  Liqun Han; Dona Lee Wong; Guochuan Tsai; Zhichun Jiang; Joseph T Coyle
Journal:  Brain Res       Date:  2007-07-17       Impact factor: 3.252

3.  Functional characterization of the GDEP promoter and three enhancer elements in retinoblastoma and prostate cell lines.

Authors:  D S Cross; J K Burmester
Journal:  Med Oncol       Date:  2007-06-27       Impact factor: 3.064

4.  Development of gene therapy using prostate-specific membrane antigen promoter/enhancer with Cre Recombinase/LoxP system for prostate cancer cells under androgen ablation condition.

Authors:  Shusei Ikegami; Takushi Tadakuma; Satoshi Suzuki; Ichiro Yoshimura; Tomohiko Asano; Masamichi Hayakawa
Journal:  Jpn J Cancer Res       Date:  2002-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.